COVID-19 rapid test

for antibodiesSARS-COV-2serum

The COVID-19 Total Antibodies Rapid Test is a lateral flow immunoassay intended for the qualitative detection of total antibodies to SARS-CoV-2 in human serum, plasma or whole blood. The COVID-19 Total Antibodies Rapid test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. The product is intended for in vitro detection of SARS-Cov-2 total antibodies in human serum, plasma or whole blood samples. Parameter of COVID-19 Total Antibodies Rapid Test Material - pp Test type - Total Antibodies Test method - Colloidal Gold Specimen - Serum, plasma or whole blood Keep temperature - 2-30℃ Certification - CE, ISO 13485:2016 Shelf-life - 18 months Package - Carton Box, 1 pc/box, 5 pcs/box, 20 pcs/box,50 pcs/box Simple. No instrumentation required&simple procedure Accuracy. Highly sensitivity specificity and accuracy Convenien. Suitable for large-scale use Test Principle This reagent is based on a lateral flow immunoassay. During the test, specimens are applied to the test cartridges. If SARS-CoV-2 antibody is present in the specimen, they combined with colloidal gold-labeled SARS-CoV-2 recombinant antigen forming antibody-virus antigen-colloidal gold complex (complex T). During lateral flow, the complex T move along nitrocellulose membrane toward one end of the absorbent paper. When passing through the line T (coated with same SARS-CoV-2 recombinant antigen), the complex T is captured by recombinant antigen resulting in coloring on line T; when passing through the line C, colloidal gold-labeled DNP is captured by quality-control antibody resulting in coloring on line C.